SCHEMBL13401237

SCHEMBL13401237

CCc1ccc(Cc2ccc(CC)cn2)cc1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 3/20 0.50
CYP1A2 P05177 1/20 0.49
CYP2D6 P10635 1/20 0.49
L3MBTL1 Q9Y468 3/20 0.43
KDM4E B2RXH2 2/20 0.43
MAPT P10636 1/20 0.43
KMT2A Q03164 1/20 0.43
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TP53 P04637 1/20 0.37
TAAR1 Q96RJ0 1/20 0.37
METAP2 P50579 1/20 0.36
PPARG P37231 1/20 0.36
CYP2A6 P11509 1/20 0.35
LPL P06858 1/20 0.35
LIPG Q9Y5X9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13401250 0.98 HRH3 (0.49) HRH3CYP1A2CYP2D6L3MBTL1KDM4E
SCHEMBL18069635 0.94 HRH3 (0.45) HRH3CYP1A2CYP2D6L3MBTL1KDM4E
SCHEMBL19415197 0.90 KMT2A (0.52) HRH3CYP1A2CYP2D6L3MBTL1KDM4E
SCHEMBL13401234 0.86 KEAP1 (0.44) HRH3CYP1A2CYP2D6L3MBTL1KDM4E
SCHEMBL20411974 0.85 HRH3 (0.45) HRH3CYP1A2CYP2D6L3MBTL1KDM4E
SCHEMBL13401245 0.84 KEAP1 (0.43) HRH3CYP1A2CYP2D6L3MBTL1KDM4E
SCHEMBL30398570 0.84 HRH3 (0.55) HRH3CYP1A2CYP2D6L3MBTL1KDM4E
SCHEMBL487617 0.84 HRH3 (0.55) HRH3CYP1A2CYP2D6L3MBTL1KDM4E
SCHEMBL10311271 0.80 HRH3 (0.36) HRH3CYP1A2CYP2D6L3MBTL1MAPT
SCHEMBL19580586 0.79 HRH3 (0.47) HRH3CYP1A2CYP2D6L3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11685863-B2 Polymerisable compounds and the use thereof in liquid-crystal displays MERCK PATENT GMBH (DE) 2023-06-27 US disclosed
US-9835890-B2 Liquid crystal display MERCK PATENG GMBH (DE) 2017-12-05 US disclosed
US-20160152894-A1 LIQUID CRYSTAL MEDIUM MERCK PATENT GMBH (DE) 2016-06-02 US disclosed
US-20150299574-A1 LIQUID CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2015-10-22 US disclosed
US-9120969-B2 Liquid crystal medium and liquid crystal display MERCK PATENT GMBH (DE) 2015-09-01 US disclosed
US-20150205158-A1 LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2015-07-23 US disclosed
US-20140077130-A1 LIQUID CRYSTAL MEDIUM AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2014-03-20 US disclosed
US-7705105-B2 A cyclic polymer of silsesquioxane skeleton with side chains formed byhydrosilation of an unsaturated end group containing an active polymerfunctional group; polyimidesiloxane copolymers; polyestersiloxane copolymers; high molecular weight; thin films; strength; heat resistance;waterproofing; CHISSO PETROCHEMICAL CORPORATION (JP) 2010-04-27 US disclosed
US-20070190344-A1 Verification of translation JNC CORPORATION (JP) 2007-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11685863-B2 Polymerisable compounds and the use thereof in liquid-crystal displays LPXN, VCL, LCP1 HRH3 4185/4885CYP1A2 4135/4885CYP2D6 3712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.